Recorded device evidence

E-Z CHECK OZONE TEST STRIPS (K132344): indications, design and recorded evidence

The acquired K132344 file contains product-specific indications and users, recorded comparison and differences, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 2 selected decisions under primary code MSY. 2 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K132344 ↗ · this pageE-Z CHECK OZONE TEST STRIPS2013-07-29 → 2014-02-25211Traditional
K243898 ↗Chlorine Sentinel II2024-12-19 → 2025-04-11113Traditional
K222167 ↗E-Z Chek Chlorine Residual Test Strips (K100-0101B)2022-07-21 → 2022-10-1889Traditional
K193169 ↗Nelson Sentinel Series Basic Chlorine Sentinel2019-11-15 → 2020-10-29349Traditional
K090338 ↗ULTRA LOW TOTAL CHLORINE, E-Z CHEK SENSITIVE TOTAL CHLORINE2009-02-10 → 2009-05-0887Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K132344 · PDF page 1 ↗ Source 2

The       Reprocessing           Products     Corporation(RPC)                  E-Z     Chek®  Ozone    Test         Strips

                                                                                                                    (K       100-0111)            are        designed      to       indicate     the
                                                                                                                     presence       of ozone          in water       used          in
                                                                                                                    hemodialysis.           The     test         strips    will       measure
                                                                                                                    equal          to  0.0,        0.05,   0.1,               0.2,     0.3,          0.4,           and
                                                                                                                    >0.5            mg/L.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Recorded comparison and differences

K132344 · PDF page 1 ↗ Source 2

The       E-Z       Chekt, Ozone     Test         Strips   (K 100-
                                                                                                                    0111)              will    detect     ozone       concentrations
                                                                                                                    equal          to  and           above    0.0           ppm          for     Ozone          in
                                                                                                                    water          used      to        prepare     dialysate.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

Performance evidence actually described

K132344 · PDF page 2 ↗ Source 3

The     data       confirms     the       product     consistently
                                                                                                                                                    generates        color   change     which          meets        the
                                                                                                                                                    color       block     for      the       reference       solution
                                                                                                                                                    concentration.                       Tlhese        data     demonstrate
                                                                                                                                                    appropriate         performance             for       use         in
                                                                                                                                                     hemodialysis    water           used       in treatment.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK132344 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryE-Z CHECK OZONE TEST STRIPS [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantReprocessing Products Corporation (Rpc) [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeMSY [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2014-02-25 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2013-07-29 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Recorded comparison and differences — what differs in our product?

    The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

    Useful evidence: Feature-by-feature differences and the underlying cited documents; no automated predicate selection.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[10481] · record 5a495bb520fca8f3a3da540fbaa36efcfb3ced9ff3b67c5b0ec548c06ec54dea
  • [4] Complete results array / fda-decision-context:K132344 · record whole dataset partition

FDA 510(k) summary — K132344 ↗

Fri, 07 Mar 2014 17:05:01 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 39497ed72a9d0e33c990f8a1cc3de8b257e769573fe25325443dbaa78b490d4d

  • [2] PDF page 1 · record 7c0913d6858540f9b52d665193d8c95b24da69e2ddc152c87d6f94f01c5e9671
  • [3] PDF page 2 · record 4dfe918d623fe7de5e030632076c2b1c53706910ab1ccc86249ec5bcf115e3cf

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services